Dorzolamide HCI
- Manufacturer
- AX Pharmaceutical Corp | Nanjing Chemlin Biomedical Science & Technology Co, Ltd.
- Effective date
- 2019-02-06
- Label type
- BULK INGREDIENT
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-01 02:49:13
Label at a glance#
ProductDorzolamide HCI
Active ingredientDORZOLAMIDE HYDROCHLORIDE
Label structure1 sections
Label contents#
Full prescribing information#
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 973dd458-49b1-1bb1-62c6-b37c4b15fe1f | Product name | 5 | 20251121 |
| 03f77cb2-b4ad-3c11-8781-787b5ece4291 | Product name | 3 | 20240507 |
| 97dad5a2-c524-a7b5-dede-82edefe9ce62 | Product name | 7 | 20220929 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 62157-704-01 | Dorzolamide HCI | 20 g in 1 JAR | POWDER | 20 | 1 |
DailyMed Dashboard NDC Coverage#
Products#
Every source-derived product name is available through these pages.
- Dorzolamide HCI
- DORZOLAMIDE HYDROCHLORIDE
- DORZOLAMIDE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 62157-704 | 62157-704-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| DORZOLAMIDE HYDROCHLORIDE | QZO5366EW7 | ACTIM |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dorzolamide Hydrochloride | DORZOLAMIDE HYDROCHLORIDE | Sagent Pharmaceuticals | 0246463c-6c24-4611-8e22-2d5254ace66a | 2026-01-09 | Warnings, Adverse reactions | DORZOLAMIDE HYDROCHLORIDE |
| Dorzolamide Hydrochloride | DORZOLAMIDE HYDROCHLORIDE | FOSUN PHARMA USA INC | ef173b63-499f-301b-e053-2995a90a4771 | 2025-09-26 | Warnings, Adverse reactions | DORZOLAMIDE HYDROCHLORIDE |
| Dorzolamide Hydrochloride | DORZOLAMIDE HYDROCHLORIDE | Gland Pharma Limited | 2023e603-12bb-4502-9f93-0126e0cc24ed | 2025-05-10 | Warnings, Adverse reactions | DORZOLAMIDE HYDROCHLORIDE |
| DORZOLAMIDE HYDROCHLORIDE | DORZOLAMIDE HYDROCHLORIDE | Advagen Pharma Ltd. | ed9d1658-43cc-4c78-b3d8-e7d980a6b673 | 2025-02-28 | Warnings, Adverse reactions | DORZOLAMIDE HYDROCHLORIDE |
| Dorzolamide Hydrochloride | DORZOLAMIDE HYDROCHLORIDE | Somerset Therapeutics, LLC | 0832960f-0a6f-4fd1-bf55-be9bebde53bd | 2025-02-12 | Warnings, Adverse reactions | DORZOLAMIDE HYDROCHLORIDE |
| Dorzolamide Hydrochloride Ophthalmic Solution | DORZOLAMIDE HYDROCHLORIDE | Micro Labs Limited | 4698e4e1-c5f6-4db1-9328-74464a85afea | 2025-01-08 | Warnings, Adverse reactions | DORZOLAMIDE HYDROCHLORIDE |
| Dorzolamide Hydrochloride | DORZOLAMIDE HYDROCHLORIDE | Alembic Pharmaceuticals Inc. | 5ad43fd4-19f0-448f-97a8-625ada4cb147 | 2024-08-27 | Warnings, Adverse reactions | DORZOLAMIDE HYDROCHLORIDE |
| Dorzolamide Hydrochloride | DORZOLAMIDE HYDROCHLORIDE | Alembic Pharmaceuticals Limited | fb2e0729-b0bc-4c3f-9961-8bb38f84a032 | 2024-08-27 | Warnings, Adverse reactions | DORZOLAMIDE HYDROCHLORIDE |
| Dorzolamide hydrochloride | DORZOLAMIDE HYDROCHLORIDE | Leading Pharma, LLC | 7d4cb6cd-86d0-41d9-baa9-bca0fa7b0694 | 2024-05-24 | Warnings, Adverse reactions | DORZOLAMIDE HYDROCHLORIDE |
| Dorzolamide Hydrochloride Ophthalmic | DORZOLAMIDE HYDROCHLORIDE | A-S Medication Solutions | fa4b8802-3271-48a4-8a91-229ebc72f570 | 2023-12-15 | Warnings, Adverse reactions | DORZOLAMIDE HYDROCHLORIDE |
| DORZOLAMIDE HYDROCHLORIDE | DORZOLAMIDE HYDROCHLORIDE | Sandoz Inc | 29157995-fa61-4425-86a5-5bd0e4718cd8 | 2022-12-20 | Warnings, Adverse reactions | DORZOLAMIDE HYDROCHLORIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
